According to GuruFocus Insider Data, the largest CFO sells during the past week were: Polaris Industries Inc., Ascena Retail Group Inc., Fusion-IO Inc., VIVUS Inc. and Affymax Inc.
Polaris Industries Inc. (PII, Financial): Vice President Finance and CFO Michael W. Malone Sold 56,000 Shares
Vice President Finance and CFO Michael W. Malone sold 56,000 shares of PII stock on 07/17/2012 at the average price of $75. Michael W. Malone owns at least 140,940 shares after this. The price of the stock has decreased by 0.4% since.
Polaris Industries Inc. designs, engineers and manufactures snowmobiles, all terrain vehicles, motorcycles and personal watercraft and markets them, together with related replacement parts, garments and accessories through dealers and distributors. Polaris Industries Inc. has a market cap of $5.07 billion; its shares were traded at around $74.7 with a P/E ratio of 21.8 and P/S ratio of 1.9. The dividend yield of Polaris Industries Inc. stocks is 2%. Polaris Industries Inc. had an annual average earnings growth of 9.6% over the past 10 years. GuruFocus rated Polaris Industries Inc. the business predictability rank of 3.5-star.
Polaris Industries Inc. has released its first quarter 2012 results ended March 31, 2012. For this quarter, the company reported net income of $60.1 million ($0.85 per share), compared to $47.3 million ($0.67 per share) in the same quarter of 2011. Net sales for the first quarter increased 25% over prior year quarter to $673.9 million.
Ascena Retail Group Inc. (ASNA, Financial): Executive Vice President and CFO Armand Correia Sold 35,000 Shares
Executive Vice President and CFO Armand Correia sold 35,000 shares of ASNA stock on 07/19/2012 at the average price of $18.89. Armand Correia owns at least 27,726 shares after this. The price of the stock has decreased by 0.32% since.
Ascena Retail Group Inc. formerly known as The Dress Barn Inc. Ascena Retail Group Inc. has a market cap of $2.91 billion; its shares were traded at around $18.83 with a P/E ratio of 14.4 and P/S ratio of 1. Ascena Retail Group Inc. had an annual average earnings growth of 17.8% over the past 10 years. GuruFocus rated Ascena Retail Group Inc. the business predictability rank of 4-star.
Ascena Retail Group Inc. has reported third quarter 2012 results for the period ended April 28, 2012. Net income for this quarter was $49.4 million, a decrease from prior year quarter’s $51.8 million. EPS was $0.31 compared to $0.32 last year. Net sales for the third quarter increased 8% from last year to $783.3 million.
Fusion-IO Inc. (FIO, Financial): CFO Dennis P. Wolf Sold 30,000 Shares
CFO Dennis P. Wolf sold 30,000 shares of FIO stock on 07/16/2012 at the average price of $18.52. Dennis P. Wolf owns at least 1,470 shares after this. The price of the stock has increased by 5.24% since.
Fusion-IO Inc. is engaged in the design, development and retail of storage memory platform that helps data decentralization. Fusion-IO Inc. has a market cap of $1.72 billion; its shares were traded at around $19.49 with a P/E ratio of 229.9 and P/S ratio of 8.7.
For its third quarter of 2012 ended March 31, 2012, Fusion-IO Inc. reported revenues of $94.2 million – up 40% from the same period in 2011. GAAP Net loss for this quarter was $4.7 million ($0.05 per share), compared to a net income of $7.0 million ($0.09 per share) prior year quarter. Gross margin was 52.1% compared to 53.2% in 2011.
Chief Technology Officer Neil A. Carson sold 13,541 shares of FIO stock on 07/16/2012 at the average price of $18.54.
VIVUS Inc. (VVUS, Financial): Vice President Finance and CFO Timothy E. Morris Sold 25,000 Shares
Vice President Finance and CFO Timothy E. Morris sold 25,000 shares of VVUS stock on 07/18/2012 at the average price of $30.36. The price of the stock has decreased by 20.09% since.
VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. VIVUS Inc. has a market cap of $2.71 billion; its shares were traded at around $24.26 with and P/S ratio of 54.1.
VIVUS Inc. reported that in its first quarter of 2012, the company had a net loss of $18.8 million ($0.20 per share), as compared to a loss of $9.9 million ($0.12 per share) prior year quarter.
CEO Leland F. Wilson sold 100,000 shares of VVUS stock on 07/18/2012 at the average price of $30.36. Multiple other insiders also sold shares of VVUS stock on 07/18/2012.
Affymax Inc. (AFFY, Financial): CFO Herb Cross Sold 25,000 Shares
CFO Herb Cross sold 25,000 shares of AFFY stock on 07/17/2012 at the average price of $16.1. Herb Cross owns at least 10,000 shares after this. The price of the stock has increased by 4.1% since.
Affymax Inc. is a biopharmaceutical company that is developing a pipeline of synthetic peptide-based drug candidates against clinically validated targets for the treatment of kidney diseases and cancer. Affymax Inc. has a market cap of $595.4 million; its shares were traded at around $16.76 with and P/S ratio of 12.5.
Affymax Inc. reported first quarter 2012 net income of $31.5 million ($0.87 per share), compared to a net loss of $9.6 million ($0.36 per share) prior year quarter. Total revenue for the first quarter of 2012 was $63.2 million compared to $16.7 million prior year quarter – an increase due mostly to $58 million in milestones earned from the company’s partner, Takeda Pharmaceutical Company Limited.
CEO John A. Orwin and Chief Commercial Officer Jeffrey H. Knapp both also sold shares of AFFY stock during the past week.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.
Polaris Industries Inc. (PII, Financial): Vice President Finance and CFO Michael W. Malone Sold 56,000 Shares
Vice President Finance and CFO Michael W. Malone sold 56,000 shares of PII stock on 07/17/2012 at the average price of $75. Michael W. Malone owns at least 140,940 shares after this. The price of the stock has decreased by 0.4% since.
Polaris Industries Inc. designs, engineers and manufactures snowmobiles, all terrain vehicles, motorcycles and personal watercraft and markets them, together with related replacement parts, garments and accessories through dealers and distributors. Polaris Industries Inc. has a market cap of $5.07 billion; its shares were traded at around $74.7 with a P/E ratio of 21.8 and P/S ratio of 1.9. The dividend yield of Polaris Industries Inc. stocks is 2%. Polaris Industries Inc. had an annual average earnings growth of 9.6% over the past 10 years. GuruFocus rated Polaris Industries Inc. the business predictability rank of 3.5-star.
Polaris Industries Inc. has released its first quarter 2012 results ended March 31, 2012. For this quarter, the company reported net income of $60.1 million ($0.85 per share), compared to $47.3 million ($0.67 per share) in the same quarter of 2011. Net sales for the first quarter increased 25% over prior year quarter to $673.9 million.
Ascena Retail Group Inc. (ASNA, Financial): Executive Vice President and CFO Armand Correia Sold 35,000 Shares
Executive Vice President and CFO Armand Correia sold 35,000 shares of ASNA stock on 07/19/2012 at the average price of $18.89. Armand Correia owns at least 27,726 shares after this. The price of the stock has decreased by 0.32% since.
Ascena Retail Group Inc. formerly known as The Dress Barn Inc. Ascena Retail Group Inc. has a market cap of $2.91 billion; its shares were traded at around $18.83 with a P/E ratio of 14.4 and P/S ratio of 1. Ascena Retail Group Inc. had an annual average earnings growth of 17.8% over the past 10 years. GuruFocus rated Ascena Retail Group Inc. the business predictability rank of 4-star.
Ascena Retail Group Inc. has reported third quarter 2012 results for the period ended April 28, 2012. Net income for this quarter was $49.4 million, a decrease from prior year quarter’s $51.8 million. EPS was $0.31 compared to $0.32 last year. Net sales for the third quarter increased 8% from last year to $783.3 million.
Fusion-IO Inc. (FIO, Financial): CFO Dennis P. Wolf Sold 30,000 Shares
CFO Dennis P. Wolf sold 30,000 shares of FIO stock on 07/16/2012 at the average price of $18.52. Dennis P. Wolf owns at least 1,470 shares after this. The price of the stock has increased by 5.24% since.
Fusion-IO Inc. is engaged in the design, development and retail of storage memory platform that helps data decentralization. Fusion-IO Inc. has a market cap of $1.72 billion; its shares were traded at around $19.49 with a P/E ratio of 229.9 and P/S ratio of 8.7.
For its third quarter of 2012 ended March 31, 2012, Fusion-IO Inc. reported revenues of $94.2 million – up 40% from the same period in 2011. GAAP Net loss for this quarter was $4.7 million ($0.05 per share), compared to a net income of $7.0 million ($0.09 per share) prior year quarter. Gross margin was 52.1% compared to 53.2% in 2011.
Chief Technology Officer Neil A. Carson sold 13,541 shares of FIO stock on 07/16/2012 at the average price of $18.54.
VIVUS Inc. (VVUS, Financial): Vice President Finance and CFO Timothy E. Morris Sold 25,000 Shares
Vice President Finance and CFO Timothy E. Morris sold 25,000 shares of VVUS stock on 07/18/2012 at the average price of $30.36. The price of the stock has decreased by 20.09% since.
VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. VIVUS Inc. has a market cap of $2.71 billion; its shares were traded at around $24.26 with and P/S ratio of 54.1.
VIVUS Inc. reported that in its first quarter of 2012, the company had a net loss of $18.8 million ($0.20 per share), as compared to a loss of $9.9 million ($0.12 per share) prior year quarter.
CEO Leland F. Wilson sold 100,000 shares of VVUS stock on 07/18/2012 at the average price of $30.36. Multiple other insiders also sold shares of VVUS stock on 07/18/2012.
Affymax Inc. (AFFY, Financial): CFO Herb Cross Sold 25,000 Shares
CFO Herb Cross sold 25,000 shares of AFFY stock on 07/17/2012 at the average price of $16.1. Herb Cross owns at least 10,000 shares after this. The price of the stock has increased by 4.1% since.
Affymax Inc. is a biopharmaceutical company that is developing a pipeline of synthetic peptide-based drug candidates against clinically validated targets for the treatment of kidney diseases and cancer. Affymax Inc. has a market cap of $595.4 million; its shares were traded at around $16.76 with and P/S ratio of 12.5.
Affymax Inc. reported first quarter 2012 net income of $31.5 million ($0.87 per share), compared to a net loss of $9.6 million ($0.36 per share) prior year quarter. Total revenue for the first quarter of 2012 was $63.2 million compared to $16.7 million prior year quarter – an increase due mostly to $58 million in milestones earned from the company’s partner, Takeda Pharmaceutical Company Limited.
CEO John A. Orwin and Chief Commercial Officer Jeffrey H. Knapp both also sold shares of AFFY stock during the past week.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.
